1. Home
  2. GEVO vs BNTC Comparison

GEVO vs BNTC Comparison

Compare GEVO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gevo Inc.

GEVO

Gevo Inc.

HOLD

Current Price

$2.50

Market Cap

568.2M

Sector

Industrials

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$10.24

Market Cap

411.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEVO
BNTC
Founded
2005
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
568.2M
411.4M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
GEVO
BNTC
Price
$2.50
$10.24
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$6.42
$27.67
AVG Volume (30 Days)
3.8M
161.7K
Earning Date
03-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
58.82
80.94
EPS
N/A
N/A
Revenue
$711,000.00
N/A
Revenue This Year
$19.44
N/A
Revenue Next Year
$5.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$9.85
52 Week High
$2.95
$17.15

Technical Indicators

Market Signals
Indicator
GEVO
BNTC
Relative Strength Index (RSI) 67.54 36.87
Support Level $2.25 $10.10
Resistance Level $2.95 $14.02
Average True Range (ATR) 0.14 0.64
MACD 0.01 -0.13
Stochastic Oscillator 92.11 3.32

Price Performance

Historical Comparison
GEVO
BNTC

About GEVO Gevo Inc.

Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: